How Many Thymocytes Audition for Selection? by Merkenschlager, Matthias et al.
 
1149
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/97/10/1149/10 $2.00
Volume 186, Number 7, October 6, 1997 1149–1158
http://www.jem.org
 
How Many Thymocytes Audition for Selection?
 
By Matthias Merkenschlager,
 
*
 
 Daniel Graf,
 
*
 
 Matthew Lovatt,
 
*
 
Ursula Bommhardt,
 
‡
 
 Rose Zamoyska,
 
‡
 
 and Amanda G. Fisher
 
*
 
From the 
 
*
 
Lymphocyte Development Group, Medical Research Council Clinical Sciences Centre, 
Royal Postgraduate Medical School, Hammersmith Hospital, London W12 0NN, United Kingdom; 
and 
 
‡
 
Division of Molecular Immunology, National Institute of Medical Research, London,
United Kingdom
 
Summary
 
T cell maturation requires the rearrangement of clonotypic T cell receptors (TCR) capable of
interacting with major histocompatibility complex (MHC) ligands to initiate positive and neg-
ative selection. Only 3–5% of thymocytes mature to join the peripheral T cell pool. To inves-
tigate the basis for this low success rate, we have measured the frequency of preselection thy-
mocytes capable of responding to MHC. As many as one in five MHC-naive thymocytes show
upregulation of activation markers on exposure to MHC-expressing thymic stroma in short-
term reaggregate culture. The majority of these cells display physiological changes consistent
with entry into the selection process within 24 h. By exposing TCR transgenic thymocytes to
a range of MHC–peptide complexes, we show that CD69 induction is indicative of thymocyte
selection, positive or negative. Our data provide evidence that the fraction of thymocytes that
qualify to enter the thymic selection process far exceeds the fraction that successfully complete
it, and suggest that most MHC-reactive thymocytes are actively eliminated in the course of se-
lection.
 
T
 
he realization more than two decades ago that T cells
recognize antigen in the context of MHC molecules
(1, 2) raised the issue of how efficient cooperation between
TCR and MHC molecules is achieved during T cell devel-
opment. This task is considerable since MHC alleles are
highly polymorphic, and not genetically linked to TCR
loci. The latter undergo somatic recombination involving
essentially random use of multiple germline-encoded gene
segments (combinatorial diversity) and deliberate DNA
template-independent variability (3–5). These mechanisms,
which ensure sufficient TCR diversity, might be predicted
to generate only very few cells with receptors competent to
productively engage MHC–peptide complexes. Indeed,
the vast majority (95–97%) of CD4 CD8 double-positive
(DP)
 
1
 
 thymocytes are thought to die in situ (6), and only a
small minority of 3–5% thymocytes reach the single-posi-
tive (SP) stage (7, 8). However, these figures do not reveal
how many thymocytes are initially recruited into the selec-
tion process by productive interactions with MHC–peptide
complexes. Further, it is not known how many of the ini-
tially recruited thymocytes fail to complete their develop-
ment, be it as a result of negative selection or due to other
factors, e.g., the availability of stromal cell environments
able to support maturation (8–10), changing activation re-
quirements during the DP to SP transition, (11, 12), or
wastage during attempts to match TCR specificity and
coreceptor expression (13).
The impact of thymocyte deletion on mature T cell pro-
duction has been studied in mice with an impaired ability
to negatively select. Surh and Sprent (6) analyzed mice that
lack MHC molecules (and consequently cannot negatively
select) by histological analysis of thymocyte death in situ.
They found as many dying thymocytes as in wild-type
controls and concluded that negative selection has no mea-
surable impact on thymocyte death, and that the vast ma-
jority of thymocytes that die do so because they are not se-
lected at all (6). Recently, Laufer et al. (14) produced mice
in which MHC class II molecules were expressed selec-
tively by cortical epithelium, resulting in CD4 T cell matu-
ration in the absence of class II–dependent selection by
bone marrow–derived cells. 5% of CD4 T cells generated
in these mice responded to syngeneic class II–expressing
cells, suggesting that in normal mice, negative selection re-
moves a minimum of 5% of the selected repertoire (
 
z
 
1/
500 DP thymocytes, assuming a normal DP to SP conver-
sion rate of 3–5%). Van Meerwijk et al. (15) suggested that
 
1
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b
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b
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8
 
, deficient; DP,
double positive; HPRT, hypoxanthine guanine phosphoribosyl trans-
ferase; mRNA, messenger RNA; rag, recombination-activating gene;
RT, reverse transcriptase; SP, single positive; TdT, terminal deoxynucle-
otidyl transferase.
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the impact of negative selection was in fact 10-fold greater
than the estimate by Laufer et al. (14), based on the pro-
duction of CD4 SP thymocytes in radiation bone marrow
chimeras. CD4 SP thymocytes were twice as frequent in
chimeras expressing MHC class II on host tissues (including
thymic epithelial cells) but lacking class II on bone mar-
row–derived cells compared to control chimeras expressing
class II on both host and graft tissues. The authors attrib-
uted this difference to negative selection by bone marrow–
derived cells and suggested that in normal mice at least 50%
of the initially selected repertoire is subject to deletion (15).
Early suggestions that TCRs might have an intrinsic af-
finity for MHC (16) were fuelled by the high frequencies
with which mature, postselection T cells respond to alloge-
neic MHC molecules (i.e., MHC molecules they were not
selected on; see review in reference 17). The idea was sup-
ported by transfection experiments in which combinations
of unrelated TCR 
 
a
 
 and 
 
b
 
 chains were able to confer allo-
recognition (18). Subsequent studies analyzed the reper-
toire of CD4 T cells selected on a very limited set of
MHC–peptide ligands (19–23), or generated in the absence
of MHC molecules (24). Invariably, the resulting T cells
responded strongly to allogeneic MHC class II, and also to
normal, syngeneic class II–peptide complexes. In one
study, as many as two thirds of T cell hybridomas generated
from CD4 cells selected on a single MHC–peptide com-
plex responded to the same MHC molecule displaying the
normal spectrum of associated peptides, providing an esti-
mate of how many thymocytes might have been deleted
had the selection process occurred on the normal spectrum
of MHC–peptide complexes (22). Based on the assumption
that TCR–MHC-peptide interactions which mediate ma-
ture T cell activation would delete DP thymocytes, such
extrapolations have important limitations. The frequency
of cells subject to negative selection may be underestimated
because MHC–peptide ligands that delete DP cells do not
always activate mature T cells (e.g., reference 25). Vice
versa, MHC–peptide ligands that activate mature T cells
may not necessarily delete DP thymocytes (e.g., reference
26). Perhaps the most serious problem with using mature T
cell reactivity as the basis to estimate TCR–MHC-peptide
interactions relevant to thymocytes is that the requirements
for positive selection and mature T cell activation are al-
most invariably different (11, 26–28) and mature T cells do
not respond by full activation to the ligands by which they
were selected (see review in reference 11). TCR–MHC-
peptide interactions that drive positive selection can there-
fore not be reliably inferred from mature T cell reactivity.
In this report, we present a more direct approach to ad-
dress this problem. In particular, we determine how many
preselection thymocytes are capable of productive interac-
tion with MHC ligands. The frequencies we observe are
high and suggest that the low success rate of thymocyte
maturation cannot simply be due to a low frequency of
cells capable of participating in the selection process, but
rather reflects other factors actively limiting thymic T cell
production.
 
Materials and Methods
 
Thymus Reaggregate and Activation Cultures.
 
Thymic stroma was
prepared by trypsinization of deoxyguanosine-treated fetal thymi
(29), and centrifugation over 55% Percoll (Pharmacia, Piscataway,
NJ). In some experiments, residual CD45-expressing cells were
removed using immunomagnetic beads (Dynal, Oslo, Norway).
Reaggregates were established from 2 
 
3
 
 10
 
5
 
 stromal cells and 4
 
3
 
 10
 
5
 
 thymocytes, and cultured as described (10). In contrast to
earlier studies (e.g., references 29 and 30), antibodies to MHC
products or to CD3 were not used in the preparation of stromal
cells and thymocytes to avoid interference with TCR recognition
and alterations in thymocyte behavior (31, 32).
To assess CD69 induction by TCR–MHC-peptide interac-
tions of known affinity, OT-I TCR transgenic/recombination-
activating gene RAG-1
 
8
 
/
 
b
 
2 microglobulin (
 
b
 
2m)
 
8
 
 thymi were cut
into small fragments and cultured in the presence of 5 
 
m
 
g/ml hu-
man 
 
b
 
2m and the indicated peptides (20 
 
m
 
M) as described (28).
 
Flow Cytometry.
 
Cells were counted by phase-contrast mi-
croscopy and stained as described (10) using CD4-PE, -FITC
(both Caltag Labs., South San Francisco, CA) or –red 613
(GIBCO BRL, Gaithersburg, MD), CD8a-red 613 (GIBCO
BRL) or -FITC (Caltag Labs.), CD69-biotin streptavidin-FITC,
CD5-FITC, CD24 (HSA)-FITC (all from PharMingen, San Di-
ego, CA), or anti-HY TCR (T3.70) and goat anti–mouse IgG-
PE (Caltag Labs.).
To quantitate DP thymocytes activated by MHC encounter in
vivo, thymocytes from young adult MHC
 
8
 
 and class I
 
1
 
 mice were
stained with CD4–red 613, CD5-FITC, and CD69-biotin followed
by streptavidin (SA)-PE. Thymocytes from class II
 
1
 
 mice were
stained with CD8-red 613, CD5-FITC, and CD69-biotin–SA-PE.
DiOC6 or hydroethidine (Molecular Probes Inc., Eugene,
OR) were used in combination with either CD4 or CD8 and
CD5 or CD69 as markers for cells entering apoptosis (33). For
population turnover studies, thymocytes labeled with PKH26
(Sigma Chemical Co., St. Louis, MO) according to the distribu-
tor’s instructions were cultured and stained for CD4 and CD8 or
activation markers. PKH26 was detected in the FL-2 channel.
Samples were analyzed by FACScan
 
Ò
 
 (Becton Dickinson, Moun-
tain View, CA), excluding dead cells by light scatter and uptake
of propidium iodide (3 
 
m
 
g/ml).
 
Reverse Transcriptase PCR.
 
Thymocytes recovered from re-
aggregate cultures were stained and sorted according to light scat-
ter and activation markers on a FACSort
 
Ò
 
 modified to allow sam-
ple cooling. RNA from 5 
 
3
 
 10
 
4
 
 to 2 
 
3
 
 10
 
5
 
 cells was reverse
transcribed (SuperscriptII; GIBCO BRL) and amplified by PCR
(SuperTaq; HT Biotechnology, Cambridge, UK) for 33 cycles,
60
 
8
 
C annealing temperature, with the primers RAG-1/32
CCAAGCTGCAGACATTCTAGCACTC; RAG-1/593 CAA-
CATCTGCCTTCACGTCGATCC; RAG-2/91 CACATCCA-
CAAGCAGGAAGTACAC; RAG-2/562 GGTTCAGGGA-
CATCTCCTACTAAG; hypoxanthine guanine phosphoribosyl
transferase (HPRT)/41 GGCTTCCTCCTCAGACCGCTTT;
HPR T/742 AGGCTTTGTATTTGGCTTTTCC; CD4-5
 
9
 
AACTGGTTCGGCATGACACTCTC; CD4-3
 
9
 
 CAGGGG-
CCACCACTTGAACTAC; CD8-5
 
9
 
 CCCCCACCCAGAGAC-
CCAGAAG; CD8-3
 
9
 
 TCCAAGGCCCAGTCCAAGAAGAGT.
 
Functional Studies.
 
Thymi from newborn MHC
 
8
 
 or MHC
class II
 
1
 
 mice were cut in four and cultured where indicated with
1–2 
 
m
 
g/ml of a bispecific anti-CD3/CD4 reagent incorporating
F(ab
 
9
 
) engineered to heterodimerise via fos/jun leucine zippers
(34). As described in detail elsewhere (35), this treatment gener-
ates phenotypically mature CD4 SP thymocytes in the absence of 
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MHC molecules. Cell suspensions were prepared 96 h later and
cultured overnight at 2 
 
3
 
 10
 
6
 
 cells/ml to deplete adherent
stroma. Limiting dilution assays were done as described (36) with
mitomycin C–treated CBA/Ca and MHC
 
8
 
 splenocytes as stimu-
lators and controls, respectively. T cell blasts prepared by stimula-
tion of thymocytes with plate-bound TCR antibody (H57,
PharMingen), 3 ng/ml PMA, and 20 U/ml IL-2 were fused to
TCR-deficient BW5147 thymoma cells as described (37), and
those expressing TCR and CD4 were tested for reactivity against
MHC class II–transfected L cells in a standard CTLL2 assay (37).
A stimulation index 
 
.
 
10 over control L cell transfectants in at
least two experiments was taken to indicate MHC reactivity.
 
Results
 
Visualization of Preselection Thymocyte Responses to MHC.
 
We examined the MHC reactivity of preselection thy-
mocytes using MHC-naive thymocytes from MHC-defi-
cient (MHC
 
8
 
) mice (13). In these experiments, MHC
 
8
 
CD4
 
1
 
CD8
 
1
 
 thymocytes were exposed to MHC
 
1
 
 thymic
stroma in reaggregate culture (10, 29) under conditions that
rescue the development of mature, SP thymocytes (Fig. 1,
day 5). The frequency of MHC-responsive cells was moni-
tored using the activation marker CD69 (4, 37a, 38). Con-
trary to our initial expectations, a substantial fraction (15%)
of MHC
 
8
 
 thymocytes expressed CD69 24 h after exposure
to MHC
 
1
 
 (H-2
 
b
 
) thymic stroma, at a time when the num-
ber of cells recovered was close to input (see below). This
value, when compared to 0.8% and 0.2% CD69-positive cells
seen in reaggregates with MHC
 
8
 
 stroma or MHC
 
8
 
 thy-
mocytes ex vivo (Fig. 1, 
 
top
 
) suggests that a considerable pro-
portion of MHC-naive thymocytes are potentially MHC re-
sponsive.
 
Defining the Requirements for CD69 Induction.
 
To deter-
mine whether the CD69 upregulation measured in these
experiments is likely to reflect biologically relevant interac-
tions, we took advantage of a well-characterized TCR
transgenic system. The OT-I TCR (28), specific for an
ovalbumin-derived peptide in the context of K
 
b
 
, was
crossed onto a recombination-deficient (Rag-1
 
8
 
; reference
39) and nonselecting background (
 
b
 
2m
 
8
 
; reference 40).
Relevant MHC–peptide complexes can be restored by the
addition in thymic organ culture of exogenous K
 
b
 
-binding
peptides and 
 
b
 
2m (28). Since both the biological effects of
the resulting K
 
b
 
–peptide complexes on thymocyte matura-
tion and mature T cell activation (4, 41–43) and their abil-
ity to bind the OT-I TCR (44) are extensively docu-
mented, we sought to compare CD69 induction with these
parameters. The agonist, negatively selecting peptide SIIN-
FEKL caused strong CD69 expression by many of the re-
maining cells (Fig. 2). Similarly, CD69 was strongly in-
duced by the E1 analogue, a peptide that mediates positive
(and in our tests, also some negative) selection of OT-I
transgenic thymocytes, and is an antagonist/partial agonist
for mature OT-I transgenic T cells. The K
 
d
 
 (off/on) values
of OT-I/K
 
b
 
–SIINFEKL and OT-I/K
 
b
 
–E1 interactions are
6.5 and 22.6 
 
m
 
M, respectively (44). Other positively select-
ing antagonist peptides, including V-OVA (K
 
d
 
 29.8 
 
m
 
M)
and R4 (not shown; K
 
d
 
 57.1 
 
m
 
M) also stimulated substan-
tial CD69 expression (but no apparent deletion). Moderate
expression of CD69 was induced by a CP
 
a
 
1-derived pep-
tide, a candidate endogenous ligand for positive selection of
OT-I thymocytes (41). In contrast, K4, an analogue pep-
tide that despite a measurable affinity for the OT-I TCR
(K
 
d
 
 OT-I/K
 
b
 
–K4 
 
z
 
360 
 
m
 
M; reference 44) fails to drive
OT-I transgenic thymocyte maturation did not induce
CD69 upregulation in our assay, and neither did a K
 
b
 
-binding
control peptide, vesicular stomatitis virus (VSV). Thus, in this
experimental system we find a very strong correlation between
biologically relevant TCR–MHC-peptide interactions and
CD69 upregulation. Interactions that drive thymocyte positive
or negative selection resulted in CD69 upregulation, whereas
interactions without effect on thymocyte maturation did not.
 
Additive Responses to MHC Class I and Class II.
 
CD69 in-
duction was used to further quantitate and dissect MHC re-
sponses by preselection thymocytes. To estimate how
many thymocytes have receptors capable of interacting
with either MHC class I or II, MHC
 
8
 
 thymocytes were re-
aggregated with stroma selectively expressing either class I
or II molecules. As shown in Fig. 3 
 
a
 
 (and summarized in
Table 1), 4.7, 7.0, and 14.9% of thymocytes were respon-
sive to stroma bearing class I or class II (A
 
b
 
) alone or the
entire H-2
 
b
 
 haplotype, as judged by CD69 expression. Up-
Figure 1. MHC-dependent activation and developmental rescue of
MHC-naive thymocytes. Thymocytes from MHC8 mice are arrested at
the CD41CD81 stage and lack selection-associated activation markers.
Coculture with MHC1 (H-2b) but not with MHC8 thymic stroma results
in CD69 expression, and rescues the development of CD4 and CD8 sin-
gle-positive HSAlow cells (5-d displays are gated on HSAlow cells). 
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regulation of the thymocyte activation/maturation marker
CD5 (4, 31, 45) was seen with similar frequencies (Fig. 3 
 
a
 
,
Table 1). As shown in Fig. 3 
 
a
 
 and summarized in Table 1,
the frequency of thymocytes responsive to MHC class I
and II individually or in combination was approximately
additive, indicating that most MHC responses in this assay
are selective for either class I or II molecules. In experi-
ments summarized in Table 1, we asked whether the pro-
vision of stroma bearing two MHC haplotypes could ele-
vate the proportion of activated thymocytes still further. As
shown, reaggregation with stroma expressing both H-2
 
b
 
and H-2
 
k
 
 induced upregulation of CD69 and CD5 in 17.7
and 22.9% of MHC
 
8
 
 thymocytes, as compared to 10.1 and
18.5% in response to H-2
 
b
 
 alone (Table 1). Therefore, at
least one in five MHC-naive thymocytes appear capable of
MHC recognition.
One of the least predictable aspects of the TCR rear-
rangement process is template-independent variability due
to the activity of TdT (see review in reference 5). Since
TdT activity is developmentally regulated with a postnatal
onset, we compared MHC responses by MHC-naive thy-
mocytes isolated from newborn mice and from 2-wk-old
mice in parallel. As summarized in Table 2, the frequency
of MHC responses was not substantially affected by TdT
activity.
 
MHC-responsive Thymocytes Have Features Consistent with
Entry into the Selection Process.
 
The early stages of thymocyte
selection are associated with characteristic changes in gene
expression (4). In particular, the described loss of Rag-1
and -2, and the transient downregulation of CD4 and CD8
messenger RNA (mRNA; 38, 46, 47) provided an oppor-
tunity to assess at the population level the consequences of
MHC recognition in our assay (with the rationale that loss
of expression would be visible only if it affected a majority
of the population analyzed). Thymocytes recovered from
short-term reaggregate cultures were separated into CD69-
positive and -negative populations and analyzed by reverse
transcriptase (RT)-PCR. The CD69-positive population
had strongly reduced levels of mRNA for the recombina-
tion-activating genes RAG-1 and -2 (Fig. 3 b, lane 3),
whereas RAG transcripts remained abundant in activation
marker–negative cells from the same cultures (Fig. 3 b, lane
2) and in MHC8 thymocytes exposed to MHC-deficient
stroma (Fig. 3 b, lane 1). Similarly, expression of CD4 and
CD8 was perturbed in activation marker–positive thy-
mocytes (Fig. 3 b, lane 3). HPRT served as a control and
remained unaffected throughout. It appears that the 15–
18% of thymocytes that respond to MHC encounter in re-
aggregate culture do so in a manner indicative of TCR en-
gagement and entry into the early stages of thymic selection
in vivo (4, 31, 37a, 38, 45, 46).
Recruitment of Preselection Thymocytes by MHC Is Cell Au-
tonomous and Reflects Cognate TCR Interactions. To clarify
whether the activation marker upregulation analyzed in
previous experiments requires (and reflects) cognate TCR–
MHC interactions by individual thymocytes, we exploited
thymocytes manipulated to express a single, HY-specific
TCR (4, 39, 40). Here, as shown in Fig. 4 a, CD5 was sub-
stantially upregulated by contact with stroma bearing se-
lecting (H-2b) MHC molecules (71.6%), but not by expo-
sure to nonselecting (H-2d) stroma (3.0%), indicating a
requirement for cognate TCR–MHC interactions. To ad-
dress the possibility that the high frequency of MHC-naive
thymocytes activated on exposure to MHC-expressing
stroma (Figs. 1 and 3, Table 1) might result from indirect
“bystander” effects (where a cell activates its neighbors and
thereby amplifies the response), we compared MHC re-
Figure 2. CD69 expression by CD4 CD8 DP thymocytes is triggered
by biologically relevant TCR-MHC–peptide contact. Young adult OT-I
TCR transgenic/RAG-18/b2m8 thymi were cut into fragments and cul-
tured with or without exogenous peptides (20 mM) and exogenous b2m
to allow the reconstitution of Kb–peptide complexes as described (28).
CD69 expression was determined 24 h later. Data on thymocyte selection
and mature T cell activation are from references 28, 34–36. Kd (off/on)
values are listed in the text.1153 Merkenschlager et al.
sponses in reaggregate culture by HY TCR–transgenic
thymocytes and non-TCR–transgenic, MHC-naive thy-
mocytes cultured separately (Fig. 4 a, top and bottom, re-
spectively), or mixed together (Fig. 4 a, middle). The pres-
ence of HY TCR–transgenic thymocytes did not appreciably
alter the frequency of MHC responses among non-TCR–
transgenic, MHC-naive cells (HY TCR2), or vice versa.
To exclude that our estimates are prejudiced by the pref-
erential survival or expansion of MHC-responsive cells in
reaggregate cultures, a detailed analysis of cell recovery, vi-
ability, and turnover was performed. After 24 h, the recov-
ery of viable cells from reaggregates was close to input, and
independent of whether the stroma expressed relevant
MHC molecules (recovery was 86% of MHC-naive thy-
mocytes cultured with MHC8 stroma, 81% of MHC-naive
thymocytes cultured with MHC1 stroma, 78% of TCR
transgenic thymocytes cultured with nonselecting stroma,
and 75% of TCR transgenic thymocytes cultured with se-
lecting stroma). Between 77 and 83% of the cells recovered
from cultures with MHC8 or MHC1 stroma were lym-
phoid, and ,90% of these were metabolically intact as in-
dicated by normal mitochondrial membrane potential (not
shown) and low hydroethidine/ethidium bromide conver-
sion (Fig. 4 b, region 1; reduced mitochondrial membrane
potential and increased hydroethidine/ethidiumand con-
version are features of early apoptotic cells before DNA
fragmentation; reference 33). Furthermore, the MHC-
dependent upregulation of CD5 and CD69 reported here
was blocked by cycloheximide (not shown), and is there-
fore distinct from the aberrant expression of activation
markers reported to occur in the absence of de novo pro-
tein synthesis during thymocyte apoptosis (48). Finally,
when thymocytes were labeled before culture with the
membrane dye PKH26 (which is distributed between
daughter cells on cell division), MHC-responsive and -un-
responsive cells retained equal amounts of dye, excluding
the possibility that MHC-responsive cells are preferentially
expanded in reaggregate cultures (Fig. 4 c).
Figure 3. Preselection thymocyte responses to MHC class I and II are largely additive and, in addition to CD69, involve CD5 upregulation, downreg-
ulation of RAG-1 and -2 mRNA, and perturbed CD4 and CD8 expression. (a) Elevated CD5 and CD69 expression by MHC-naive thymocytes 24 h af-
ter contact with MHC. Note that responses to class I and II (Ab) are approximately additive. These responses are independent of superantigens, as verified
using MHC-expressing cells from mice without mouse mammary tumor virus integrants (provided by Dr. E. Simpson, data not shown). (b) Downregu-
lation of RAG-1 and -2 mRNA 24 h after MHC contact. RT-PCR analysis of thymocytes isolated by fluorescence activated cell sorting from reaggre-
gates with MHC-deficient (lane 1) or MHC1 stroma (lanes 2 and 3). The latter were separated into CD69-negative (lane 2) and -positive cells (lane 3).
RAG-1 and -2 signals are barely detectable in CD69-positive thymocytes; CD4 and, to a lesser extent, CD8a mRNA appear downregulated. RT-PCR
for HPRT serves as a control; lane 4 contains no cDNA.
Table 1. Incremental Recruitment of MHC-naive Thymocytes by 
MHC Class I, Class II, One Haplotype (H-2b), and Two 
Haplotypes (Hbxk)
Stroma % CD69 induction % CD5 induction
mean 6 1 SD n mean 6 1 SD n
MHC8 1.1 6 0.6 (23) 1.8 6 0.7 (13)
Class I1 (H-2b) 5.7 6 2.0 (22) 10.3 6 6.2 (12)
Class II1 (Ab) 8.2 6 3.3 (19) 11.2 6 3.7 (11)
MHC1 (H-2b) 10.1 6 2.5 (15) 18.5 6 2.9 (6)
MHC1 (H-2bxk) 17.7 6 7.0 (18) 22.9 6 7.9 (13)
Table 2. MHC-naive Thymocytes Isolated from Mice Aged ,3 d 
or .2 wk (Before and After the Onset of TdT Expression) Respond to 
MHC with Similar Frequencies
% CD69 induction
Pre-TdT (,3 d) Post-TdT (.2 wk)
mean 6 1 SD n mean 6 1 SD n
MHC8 1.4 6 0.5 (6) 1.0 6 0.7 (7)
Class I1 (H-2b) 6.6 6 1.3 (9) 6.1 6 2.7 (5)
Class II1 (Ab) 10.5 6 2.6 (5) 8.3 6 3.4 (7)
MHC1 (H-2b) 11.1 6 1.3 (5) 10.4 6 3.5 (4)
MHC1 (H-2bxk) 15.8 6 2.7 (5) 13.0, 21.2 (2)1154 How Many Thymocytes Audition for Selection?
Similar Frequencies of MHC-responsive Thymocytes In Vitro
and In Vivo. The data presented above suggest that a large
fraction of thymocytes can respond to MHC under in vitro
conditions that support thymocyte differentiation. To de-
termine if this potential is actually realized in vivo, we ana-
lyzed the expression of activation markers on CD41CD81
DP thymocytes freshly isolated ex vivo. Compared to
MHC8 thymocytes, 27.6 6 3.5% (n 5 9) of C57Bl/10 (H-
2b) DP thymocytes expressed elevated CD5 levels (not
shown), and elevated CD5 and/or CD69 expression was
detectable in .20% of DP thymocytes from mice express-
ing MHC class I or II (Ab) selectively (Fig. 5). These fre-
quencies are slightly higher than those determined using
MHC8 thymocytes in vitro, possibly because successful
TCR engagement can halt further TCR a chain rear-
rangements (see review in reference 4), and thereby permit
the accumulation of MHC-responsive receptors in vivo.
Analysis of the Preselection Repertoire Using Mature T
Cells. Previous estimates suggest that as many as 1–10% of
mature, postselection T cells can respond to allogeneic
MHC products, and it has been argued that this observa-
tion is not readily accounted for by models for thymic se-
lection (17). To explore the nature of this responsiveness to
MHC, we attempted a direct comparison of MHC reactiv-
ity among MHC-naive and MHC class II–selected CD4 T
cells (Fig. 6). Preculture with bispecific (CD3/CD4) anti-
bodies (34) was used to drive thymocyte maturation in the
absence of MHC selection (24, 35, 49, 50). In contrast to
untreated MHC8 thymi, MHC8 thymi exposed to CD3/
CD4 bispecific antibodies generated percentages of CD4
SP thymocytes similar to MHC class II1 thymi (Fig. 6 a).
Comparing MHC-naive and MHC class II-selected CD4
T cells by limiting dilution analysis, we found similar fre-
quencies of alloreactive cells (1/757 and 1/691 thymocytes,
respectively, or 1/621 and 1/587 CD4 cells, Fig. 6, b and c).
T cell hybridomas were generated from MHC-naive
(CD3/4 hybrid antibody treated) and MHC class II–selected
CD4 cells and tested for MHC reactivity. To exclude re-
sponses to class II–presented superantigens, a panel of MHC
class II transfected L cells was used as stimulator cells (Fig. 6
d). 8 of 95 (8.4%) and 13 of 99 (13.1%) T cell hybridomas
generated from MHC-naive and class II–selected CD4
cells, respectively, responded to at least one of five class II
transfectants. Several Ab-selected thymocyte hybridomas
Figure 4. Bystander activation, unscheduled display of activation mark-
ers during apoptosis, or preferential expansion do not account for the fre-
quency of MHC responsive thymocytes. (a) CD5 induction by cognate
TCR–MHC interactions. HY TCR transgenic thymocytes from RAG-
1–deficient mice lacking MHC class I expression respond strongly to se-
lecting (H-2b), but not to nonselecting (H-2d) MHC molecules (top; Note
that in contrast to an earlier study [45], our experiment excludes endoge-
nous TCR rearrangements by using RAG-1–deficient thymocytes). Re-
aggregates containing mixtures of HY TCR transgenic and MHC-naive,
TCR nontransgenic thymocytes (middle) show that both populations re-
spond independently, and without significant bystander activation (com-
pare top and bottom to middle). The percentage of cells in each region is in-
dicated. In the middle panel, the percentage of activated cells among
TCR transgenic and nontransgenic thymocytes is calculated separately
(percentage of total cells is given in brackets). (b) Most cells recovered
from short-term aggregate cultures are viable (i.e., exclude propidium io-
dide; PI) and metabolically intact, as indicated by low oxidative conver-
sion of hydroethidine (HE) to ethidium bromide (EBr; reference 33).
Displays in Fig. 3 a and data in Table 1 are gated on the region marked 1.
(c) MHC-responsive thymocytes do not selectively expand in short-term
culture. Thymocytes were labeled with the fluorescent membrane dye
PKH26 (Sigma Chemical Co.) before coculture with stroma for 24 h.
Control traces are of unlabeled and large (cycling) thymocytes; the latter
illustrating dye dilution on cell division. PKH26 fluorescence is the same
for MHC-responsive and -nonresponsive cells (defined by CD5 expres-
sion level).
Figure 5. In vivo expression of selection markers by CD4 CD8 DP
thymocytes. Thymocytes taken from young adult mice lacking MHC
(MHC8, left), or expressing MHC class I (middle) or class II (Ab; right), re-
spectively, were stained for CD5 and CD69. Displays are gated on
CD41CD81 double-positive cells as defined by the expression of CD4
(for thymocytes from MHC8 and class I1 mice, left and middle) or CD8
(for thymocytes from class II1 mice, right). The percentages of cells ex-
pressing elevated levels of CD5, CD69, or both are indicated in the re-
spective quadrants. Although this analysis is representative of H-2b mice,
up to 50% of DP thymocytes are apparently engaged in the selection pro-
cess in MHC haplotypes expressing class II E products (not shown).1155 Merkenschlager et al.
responded to Ab-transfected L cells, probably reflecting an
altered spectrum of MHC-associated peptides displayed by
L cells in the absence of H-2M and invariant chain (51),
since none of twenty Ab-selected hybridomas, but 2 of 20
antibody-generated thymocyte hybridomas tested re-
sponded to H-2b spleen cells (data not shown). Five hybri-
domas generated from MHC-naive cells and two hybrido-
mas generated from class II–selected cells responded to
more than one transfectant, perhaps indicating a trend to-
wards greater cross-reactivity in the preselection as com-
pared to the postselection repertoire. In conclusion, the
preselection repertoire clearly contains TCRs able to con-
fer MHC reactivity to mature T cells, and at frequencies
similar to the repertoire that results from selection by MHC.
Discussion
The extent to which the preselection TCR repertoire is
MHC responsive had previously been addressed by extrap-
olation from mature T cell reactivity (14, 22, 24; see intro-
duction). This approach is ultimately limited because of
potential and reported differences in the responsiveness of
preselection thymocytes versus mature T cells; MHC–pep-
tide ligands may delete DP cells without activating mature
T cells (25) and vice versa (26), and TCR-MHC-peptide
interactions that drive positive selection do not generally
meet the activation requirements of mature T cells (11, 26–
28, 41, 43).
We have taken a direct approach to evaluate the MHC
responsiveness of preselection thymocytes. MHC-naive
thymocytes were exposed to MHC-expressing thymic
stroma in short-term reaggregate cultures, and the induc-
tion of the activation/selection markers CD69 and CD5
was measured by flow cytometry under conditions where
most thymocytes seeded into the cultures could be recov-
ered for quantitative analysis. We show that the frequency
with which preselection thymocytes respond to MHC is
high, exceeding or at least matching the highest estimates
made by extrapolations from responses of normal postselec-
tion T cells to allogeneic MHC (17), MHC responses by
CD4 T cells selected on restricted MHC–peptide com-
plexes (22), or CD4 T cells generated independently of
MHC (24). In our experiments, on average one in five pre-
selection thymocytes responded to stroma expressing two
parental MHC haplotypes. Control experiments ruled out
several trivial explanations for this high frequency, includ-
ing noncognate (e.g., coreceptor–MHC) interactions, the
selective expansion or survival of MHC-responsive cells,
the activation of bystanders that do not themselves see
MHC, and the aberrant expression of activation markers by
thymocytes in the early stages of apoptosis. Consistent with
our observations in vitro, DP thymocytes analyzed ex vivo
showed similar frequencies of activation marker–positive
cells.
It has been estimated that four of nine thymocytes lack a
functional TCR because they fail to produce in-frame
TCR a chain rearrangements (52). In this scenario, as
many as one in three successfully rearranged TCR would
have to confer MHC reactivity to preselection thymocytes
to account for the frequencies of MHC-responsive thy-
mocytes reported here (if rearrangement is attempted for
Figure 6. MHC-naive CD4 T cells respond to MHC. (a) Treatment of
MHC8 thymi with CD3/CD4 bispecific antibodies generates CD4 SP
cells phenotypically and functionally similar to CD4 SP cells selected by
MHC class II. (b) Limiting dilution analysis indicates that MHC-naive
and class II–selected CD4 cells mount proliferative responses to allogeneic
CBA/Ca splenocytes with similar frequencies, whereas MHC-naive thy-
mocytes not treated with bispecific antibodies mount no detectable re-
sponses. (c) Graphic representation of experiment 2. Shaded areas indicate
95% confidence limits. (d) T cell hybridomas were generated from MHC-
naive and class II–selected CD4 cells, and tested for reactivity to a panel of
MHC class II transfected L cells. 8 of 95 (8.4%) and 13 of 99 (13.1%), re-
spectively, responded to at least one class II transfectant, five hybridomas
generated from MHC-naive cells and two hybridomas generated from
class II–selected cells responded to two transfectants.1156 How Many Thymocytes Audition for Selection?
both alleles, and the net effect of sequential rearrangements
is nil in the absence of MHC molecules to provide feed-
back on the rearrangement process; reference 4). Since the
MHC responses observed were largely additive (Fig. 2 a,
Table 1), additional MHC products would be expected to
reveal an even greater proportion of responsive TCRs.
It appears that the evolutionary partnership between
TCR and MHC has streamlined TCR rearrangement to-
wards maximal variability in domains interacting predomi-
nantly with MHC-bound peptides, while minimally inter-
fering with MHC interactions. These conditions would be
met by the preferential use of germline-encoded TCR seg-
ments for MHC contacts and TCR–MHC orientation, as
suggested by theoretical considerations (16, 53) and func-
tional (3, 54) as well as structural data (55, 56). This point is
illustrated by our observation that the frequency of MHC
responses was not substantially affected by TdT activity,
even though template-independent variability due to TdT
activity represents one of the least predictable aspects of the
TCR rearrangement process (see review in reference 5).
To ask to what extent preselection TCRs would confer
MHC reactivity to mature T cells, we generated CD4 SP
thymocytes from preselection thymocytes by limited CD3/
CD4 cross-linking (35) and compared their MHC reactiv-
ity to CD4 SP thymocytes that had been selected on MHC
class II. The frequencies of MHC-responsive cells esti-
mated by limiting dilution analysis and T cell hybridoma
assays were similar for both populations, confirming that
MHC selection is not required for MHC reactivity (24).
Collectively, these data suggest a minimalist interpretation
of allo-reactivity, in which mature T cells respond to allo-
geneic MHC products not because allo-reactive TCR are
somehow selected for, but because allo-reactivity is not se-
lected against.
CD4 SP thymocytes expressing pre- or postselection
TCRs were equally MHC reactive, but at frequencies
markedly lower than pre-selection thymocytes. Only one
in several hundred CD4 SP thymocytes responded to allo-
geneic stimulator cells in proliferation assays under limiting
dilution conditions, and individual class II transfectants
were recognized on average by 2.6 of 95 (2.7%) and 3 of
99 (3.0%) pre- and postselection hybridomas, respectively.
9.7 6 1.8% MHC-naive thymocytes responded to each L
cell transfectant by expressing CD69 (compared to 2.1%
CD69 induction by control L cells expressing endogenous
H-2k MHC class I; data not shown). Perhaps predictably (if
mature and immature T cells have different activation re-
quirements), it appears that while the preselection reper-
toire confers moderate MHC reactivity to mature T cells, it
is used to greater effect by DP thymocytes to attain MHC
responsiveness, and a chance to enter the selection process.
Several lines of evidence link the observed MHC re-
sponsiveness of preselection thymocytes to thymocyte se-
lection. First, when the requirements for CD69 induction
were checked against a set of standards in the form of
MHC–peptide complexes with well-characterized effects
on thymocyte maturation, we found concordance between
interactions that trigger CD69 expression and thymocyte
selection, both positive and negative. In contrast, peptides
without detectable effects on thymocyte selection failed to
induce CD69, including one for which weak, but measur-
able TCR/MHC-peptide interactions can be demonstrated
(44). Second, the majority of activation marker–positive
thymocytes undergo physiological changes indicative of thy-
mocyte selection in vivo, including downregulation of RAG-1
and -2 (both involved in TCR rearrangement and selec-
tion), as well as CD4 and CD8 mRNA (a feature of thy-
mocytes in the DP to SP transition; references 46, 47).
Third, the expression of activation markers in reaggregate
culture was correlated with successful T cell maturation (as
demonstrated in reaggregate cultures maintained for 5 d),
and both were MHC dependent. CD69 and CD5 are ex-
pressed by selection intermediates in vivo (4, 37a, 38, 46) as
well as in reaggregate cultures (30).
If more thymocytes enter the selection process than suc-
cessfully complete it (7, 8), it is pertinent to consider evi-
dence for mechanisms that may operate to limit mature T
cell production. Even in TCR transgenic mice where all
thymocytes are potentially selectable, only 20% of DP cells
enter the SP pool (8), and the absolute number of mature T
cells produced is similar to that in normal mice (9). It ap-
pears that access to relevant MHC–peptide complexes is
not a limiting factor, because RAG expression is strongly
downregulated in the majority of cortical thymocytes (38).
Perhaps stromal cell microenvironments that can sustain
the DP to SP transition are limiting, at least in a TCR
transgenic scenario (8, 10). Since thymic selection is
aborted when thymocytes are removed from their selecting
environment, or thymocyte access to selecting ligands is
blocked experimentally (38), it is possible that thymocytes
are vulnerable because of a requirement for prolonged sig-
naling, which in turn may facilitate the matching between
TCR specificity and coreceptor expression (4, 13) as well
as the fine tuning of T cell responsiveness during the DP to
SP transition (11, 12). One can speculate that a particular
TCR may allow entry into the selection process, but fail to
sustain maturation at a later stage. Finally, negative selec-
tion must be an important candidate for limiting mature T
cell production, but, as already discussed, estimates of its
impact vary from negligible (6) to moderate (14) to over-
whelming (15, 22).
The thymus reaggregate system used in this study does
not distinguish between these possibilities because the
method to prepare thymic stroma (preculture in deoxygua-
nosine) depletes dendritic cells, important mediators of
negative selection. Nevertheless, it is provocative that the
frequency of thymocytes recruited into the thymic selec-
tion process (this study) could theoretically accommodate
even the highest estimates (15, 22). We are tempted to
speculate that the true impact of negative selection may be
closer to the estimates of Ignatowicz et al. (22) and van
Meerwijk et al. (15) than to those of Surh and Sprent (6) or
Laufer et al. (14). Surh and Sprent’s conclusion is based on
the observation that apoptotic thymocytes occur with simi-
lar frequencies in normal mice and in mice that can not
negatively select due to lack of MHC expression. Another1157 Merkenschlager et al.
view of this result would be that, regardless of how many
thymocytes normally die by negative selection, thymocyte
death in MHC-deficient mice must be at least as common
as in normal mice because DP thymocytes can not mature
in the absence of MHC expression. The estimate of Laufer
et al. (14) is based on limiting dilution analysis, an approach
likely to yield lower figures than assays on preactivated T
cell clones or hybridomas (e.g., reference 24 and this
study), which according to our data, more accurately re-
flect thymocyte response to MHC.
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